Auscann Group Holdings Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Auscann Group Holdings Ltd with three other
pharmaceutical manufacturers in Australasia:
Rhythm Biosciences Ltd
(2020
sales of 46,266.00 Australian Dollars [US$35,671.55 ]
),
Prescient Therapeutics Ltd
(70,361.00 Australian Dollars [US$54,249.03 ]
of which 100%
was Clinical stage oncology), and
Alterity Therapeutics Ltd
(17,117.00 Australian Dollars [US$13,197.38 ]
of which 100%
was Reaserch and development in the field of).
Sales Analysis.
Auscann Group Holdings Ltd reported sales of A$388,532.00 (US$299.56 thousand)
for the
fiscal
year ending
June of 2020.
This
represents
a
sharp
decrease of 54.9%
versus 2019, when the company's sales were A$861,770.00 .